Sorrento Therapeutics Inc (SRNE)
0.016
0.00 (0.00%)
USD |
OTCM |
Apr 26, 10:10
Sorrento Therapeutics Shareholders Equity (Quarterly): -205.11M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | -205.11M |
March 31, 2023 | -125.50M |
December 31, 2022 | -18.60M |
September 30, 2022 | 131.85M |
June 30, 2022 | 132.02M |
March 31, 2022 | 226.54M |
December 31, 2021 | 78.75M |
September 30, 2021 | 131.50M |
June 30, 2021 | 186.17M |
March 31, 2021 | 231.44M |
December 31, 2020 | 165.15M |
September 30, 2020 | 205.44M |
June 30, 2020 | 137.28M |
March 31, 2020 | 101.04M |
December 31, 2019 | 78.59M |
September 30, 2019 | 45.90M |
June 30, 2019 | 83.53M |
March 31, 2019 | 131.94M |
December 31, 2018 | 209.47M |
September 30, 2018 | 221.59M |
June 30, 2018 | 254.37M |
March 31, 2018 | 234.80M |
December 31, 2017 | 199.57M |
September 30, 2017 | 131.02M |
June 30, 2017 | 92.42M |
Date | Value |
---|---|
March 31, 2017 | 57.78M |
December 31, 2016 | 80.04M |
September 30, 2016 | 79.66M |
June 30, 2016 | 142.24M |
March 31, 2016 | 94.81M |
December 31, 2015 | 145.15M |
September 30, 2015 | 146.19M |
June 30, 2015 | 91.25M |
March 31, 2015 | 100.00M |
December 31, 2014 | 108.71M |
September 30, 2014 | 70.99M |
June 30, 2014 | 78.02M |
March 31, 2014 | 59.15M |
December 31, 2013 | 66.81M |
September 30, 2013 | 30.88M |
June 30, 2013 | 5.770M |
March 31, 2013 | 10.32M |
December 31, 2012 | 6.197M |
September 30, 2012 | 7.347M |
June 30, 2012 | 8.502M |
March 31, 2012 | 3.404M |
December 31, 2011 | 4.210M |
September 30, 2011 | 2.839M |
June 30, 2011 | 3.471M |
March 31, 2011 | 4.476M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-205.11M
Minimum
Jun 2023
231.44M
Maximum
Mar 2021
93.29M
Average
131.50M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Scilex Holding Co | -172.94M |
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 75.18M |
Protalix BioTherapeutics Inc | 33.57M |
Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 456.69M |
Total Liabilities (Quarterly) | 654.65M |
Debt to Equity Ratio | -0.6928 |
Current Ratio | 0.5024 |
Net Debt Paydown Yield | 1.11% |